How anti-neutrophil cytoplasmic autoantibodies activate neutrophils.
about
Neutrophil Extracellular Traps in ANCA-Associated VasculitisNeutrophil-Mediated Regulation of Innate and Adaptive Immunity: The Role of MyeloperoxidaseExperimentally-induced anti-myeloperoxidase vasculitis does not require properdin, MASP-2 or bone marrow-derived C5Reanalysis of the Rituximab in ANCA-Associated Vasculitis trial identifies granulocyte subsets as a novel early marker of successful treatmentIntravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.Phagocyte NADPH oxidase restrains the inflammasome in ANCA-induced GNImpaired phagocytosis and reactive oxygen species production in phagocytes is associated with systemic vasculitis.Clinical study of renal impairment in patients with propylthiouracil-induced small-vessel vasculitis and patients with primary ANCA-associated small-vessel vasculitis.Anti-myeloperoxidase antibodies attenuate the monocyte response to LPS and shape macrophage development.Neutrophil migration: moving from zebrafish models to human autoimmunity.Inhibitors and Antibody Fragments as Potential Anti-Inflammatory Therapeutics Targeting Neutrophil Proteinase 3 in Human Disease.Neutral serine proteases of neutrophils.Complement in ANCA-associated vasculitis: mechanisms and implications for management.Re-Examining Neutrophil Participation in GN.TLR9 Deficiency Leads to Accelerated Renal Disease and Myeloid Lineage Abnormalities in Pristane-Induced Murine Lupus.Characterization of the CD177 interaction with the ANCA antigen proteinase 3.With complements from ANCA mice.Neutrophils from vasculitis patients exhibit an increased propensity for activation by anti-neutrophil cytoplasmic antibodies.Gene silencing and a novel monoallelic expression pattern in distinct CD177 neutrophil subsets.Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis.Circulating mitochondrial DNA in serum of patients with granulomatosis with polyangiitis.Identification of coronin-1a as a novel antibody target for clinically isolated syndrome and multiple sclerosis.Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides.Sphingosine-1-phosphate and its receptors in anti-neutrophil cytoplasmic antibody-associated vasculitis.Antineutrophil Cytoplasmic Antibody and Multiple Sclerosis.Expression and role of a2 vacuolar-ATPase (a2V) in trafficking of human neutrophil granules and exocytosis.Delta Neutrophil Index Is Associated with Vasculitis Activity and Risk of Relapse in ANCA-Associated Vasculitis.Consequences of cathepsin C inactivation for membrane exposure of proteinase 3, the target antigen in autoimmune vasculitisInteraction between CD177 and platelet endothelial cell adhesion molecule-1 downregulates membrane-bound proteinase-3 (PR3) expression on neutrophils and attenuates neutrophil activation induced by PR3-ANCA
P2860
Q26742162-DF20DC55-F6CC-41E1-B09D-71B971C485C9Q26767149-22D1E5B1-2918-4062-A3FE-2EDDDE0B50EFQ27468849-8217A21B-D9E2-4543-A71E-5C1163473DA6Q28607461-8B9D27FC-D53A-4EAA-996D-A0A72514DFF0Q34377832-6988455D-D9B5-40DD-A633-198E56DF1215Q35027263-CF97AF41-CC91-42AD-A2F2-11A07236C34BQ35996558-DB50E691-D583-4A37-9399-453869C5BE56Q36986352-895C49E4-B0B4-47E7-8607-18FE7A479AEAQ37599570-D6B141A9-D6F7-435F-B1DB-00BCD242191AQ38151856-098B7D25-E6D7-4867-A871-C1E95291CBFCQ38850115-122C3D65-03E3-4241-9E4A-6DBC09620C88Q38936537-9D979668-C68E-482D-A7B3-1F368CFC41F6Q39186343-8D408AD0-D131-481F-966C-CB3CAB40D096Q39376963-F441228B-E218-4ADC-911C-0F4131A5285CQ39647280-F8DAF603-940F-41E9-98E9-8591424B0EDEQ42152311-41F24322-443A-43A5-B86C-BACC694AD1C3Q42732379-8A5884C9-D28B-4DB1-A3E5-D08125C5C430Q46914738-E836E87E-4BF1-4F27-88A4-5CC52DDC7128Q47106268-4DD5813A-9CF3-44BF-9EEF-A104EFE862C1Q47594489-8E78D706-DA5C-47BD-A514-279850D853DBQ48215573-7E22201C-4A6F-4999-8F1B-2BB520D52641Q50928201-966E7D9D-7ADC-49CE-85D5-D159BE353727Q52311683-18D1AD2E-E510-4F09-9EC7-536D7119F910Q52789739-D6D257DF-04BF-428A-ADA5-8BA9A94F56BCQ55008912-26ACD178-428D-4AA0-AF0C-69161FC8D97FQ55061316-1FDB580D-102D-46FF-962E-427A1CE82D8BQ55333498-FFCBCB6D-8409-467F-AA06-341571E2C509Q56967777-E016D219-8A39-491A-BC38-48DED18464BEQ58711730-267B7896-5CC6-401E-99D7-6773DB0B9072
P2860
How anti-neutrophil cytoplasmic autoantibodies activate neutrophils.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
How anti-neutrophil cytoplasmic autoantibodies activate neutrophils.
@en
type
label
How anti-neutrophil cytoplasmic autoantibodies activate neutrophils.
@en
prefLabel
How anti-neutrophil cytoplasmic autoantibodies activate neutrophils.
@en
P2860
P1476
How anti-neutrophil cytoplasmic autoantibodies activate neutrophils.
@en
P2093
R Kettritz
P2860
P304
P356
10.1111/J.1365-2249.2012.04615.X
P577
2012-09-01T00:00:00Z